1Fanning PM,Kuehl TJ,Lee R,et al.Video mapping to assess efficacy of an antiestrogen(raloxifene)on spontaneous endometriosis in the rbesus monkey,Macaca mulata[].Bunkey Day Proceeding.1996
2Jones RC.The effect of a luteinizing hormone-releasing hormone antagonist on experimental endometriosis in the rat[].Acta Endocrinologica.1987
3Noble LS,Simpson ER,Johns A,et al.Aromatase expression in endometriosis[].The Journal of Clinical Endocrinology.1996
4Fang Z,Yang S,Gurates B,et al.Genetic or enzymatic disruption of aromatase inhibits the growth of ectopic uterine tis-sue[].The Journal of Clinical Endocrinology.2002
5Ailawadi RK,Jobanputra S,Kataria M,et al.Treatment of endometriosis and chronic pelvic pain with letrozole and norethindrone acetate:A pilot study[].Fertility and Sterility.2004
6D′Antonio M,Martelli F,Peano S,et al.Ability of recombinant human TNF binding protein-1(r-hTBP-1)to inhibit thedevelopment of experimentally-induced endometriosis in rats[].Journal of Reproductive Immunology.2000
7D′Hooghe TM,Cuneo S,Nugent N,et al.Recombinant human TNF binding protein-1(r-hTBP-1)inhibits the development of endometriosis in baboons:A prospective,randomized,placebo-and drug-controlled study[].Fertility and Sterility.2001
8Levine Z,Efstathiou JA,Sampson DA,et al.Angiogenesisinhibitors suppress endometriosis in a murine model[].Journal of the Society for Gynecologic Investigation.2002
9Hull ML,Charnock-Jones DS,Chan CL,et al.Antiangiogenic agents are effective inhibitors of endometriosis[].The Journal of Clinical Endocrinology.2003
10Grow DR,,Williams RF,Hsiu JG,et al.Antiprogestin and/or gonadotropin-releasing hormone agonist for endometriosis treatment and bone maintenance:A1-year primate study[].The Journal of Clinical Endocrinology.1996
2Pearce CL, Templeman C, Rossing MA, et al. Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case control studies [J]. I.ancet Oncology, 2012, 13(4)= 385-394.
3Gazvani R, Templeton A. New considerations for the pathogenesis ofendometriosis[J]. Int J Gynecol Obstet, 2002, 76(2) 117- 126.
4Halme J, Hammond MG, Hulka JF. Retrograde menstruation in healthy women and in patients with endometriosis[J]. Obstet Gyneeol,1984, 64, 151-154.
5Halme J, Hammond MG, Hulka JF, et al. Retrograde menstruation in healthy women and in patients with endometriosis [J]. Obstetrics . Gynecology, 1984, 64(2): 151-154.
6Pearce CL, Templeman C, Rossing MA, et al. Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies [J]. Lancet Oncology, 2012, 13(4): 385-394.
7Kondi-Pafiti A, Papakonstantinou E, lavazzo C, et al. Clinicopathological characteristics of ovarian carcinomas associated with endometriosis[J]. Arch Gynecol Obstet, 2012, 285(2) : 479- 483.
8Pergialiotis V, Lagkadas A, Polychronis O, et al. Endometriosis- associated ovarian cancer. Presentation of a ease report and review of the literature[J]. Eur J, 2011, 32(6): 2011,334-337.
9Boyd J, Sonoda Y, Federici MG, et al. Clinicopathologic features of BRCA-linked and sporadic ovarian cancer[J]. JAMA, 2000, 283(17) : 2260-2265.
10Kobayashi H. Ovarian cancer in endometriosis: Epidemiology, natural history, and clinical diagnosis[J]. Int J Clin Oncol, 2009, 14(5) : 378-382.
